Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Shen, T. Yang, T. Wang, L. Chen, X. Li, F. Wen (Chengdu, China). Elevated serum levels of oxidized low-density lipoprotein in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 254

Member's Comments

No comment yet.

Related content which might interest you: Decreased levels of high-density lipoprotein cholesterol in patients with sarcoidosis and relationship with disease activity Source: Eur Respir J 2004; 24: Suppl. 48, 42s Year: 2004 Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles Year: 2015 LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Low-density lipoprotein cholesterol is associated with inspiratory capacity to total lung capacity ratio in AECOPD patients Source: Annual Congress 2012 - New issues in pulmonary function Year: 2012 Serum total cholesterol, HDL-C and LDL-C levels significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 860s Year: 2006 Relation of low serum lipid levels with coronary atherosclerosi in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 662s Year: 2006 APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema Source: Eur Respir J 2014; 43: 1003-1017 Year: 2014 HDL serum levels are significantly lower in patients with COPD than in never-smokers Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome Source: International Congress 2015 – COPD: notable points Year: 2015 Serum lipid levels in patients with bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Elevated serum inflammatory markers in patients with stable COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Are the thiol/disulfide redox status and HDL cholesterol levels associated with pulmonary embolism? Source: International Congress 2017 – Pulmonary embolism Year: 2017 Is serum cholesterol a risk factor for asthma? Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Relations between serum lipid levels and inflammatory markers in obese asthma. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Total cholesterol and low density lipoprotein (LDL) cholesterol in obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007